|
Method of complex therapy of fist time identified pulmonary tuberculosis For complex therapy of the first time identified pulmonary tuberculosis traditional anti-tuberculosis therapy is carried out. After two weeks of anti-tuberculosis chemotherapy, complex physiotherapy is performed. In the morning 40-60 minutes after meal ultrasound inhalation with an inhibitor of proteases contrykal in a dose of 5000 UNITS, diluted in 3-4 ml of an isotonic solution of sodium chloride is carried out. Inhalation is carried out at a temperature of the solution of 35°C for 10 minutes on the apparatus "Vulkan-1". 20 minutes after inhalation magnetic infrared laser therapy (MIL-therapy) is performed from the apparatus "Rikta-04/4" on affected zones of the lungs by contact method of the application of the apparatus emitter. Frequency of the laser impact constitutes 5-50 Hz. Average power of infrared light-diode radiation is 60±30 mW, an impact with constant magnetic field is realised with induction 35±10 mT for 1-5 min. The course of treatment constitutes 30-40 daily procedures as well. |
|
|
Dosing device for creation of gas flow with active substance finely dispersed in it Invention relates to medical equipment. Dosing device includes mouth piece, first flow gas channel, dosing chamber, which has possibility to be from time to time located in the area of first flow gas channel, and device for unlocking dosing chamber, containing separating element made with possibility of travel between closed state and open state and guiding element of sliding, on which separating element travels between closed position and open position and is brought into motion due to rarefaction applied to mouth piece. When separating element is in closed position, first flow gas channel is blocked, and when it is in open position, first flow gas channel is open. Separating element and/or guiding element of sliding in the area of sliding contact is provided with producing impact on friction properties sliding element, which ensures triggering separating element and opening of dosing chamber. |
|
|
Invention relates to medical equipment, namely to dosing device for inhalation of powder0like substance, in particular, of medical type, which is located in storage chamber above the bottom that moves after it and is intended for transfer from chamber into ready position for output, which contains indication (A), corresponding to the level if filling, in zone of device wall. To improve dosing device of aid type, in particular, with respect to improved indication, it is suggested that indication (A) consists of belt strap, carried by the bottom and changing direction by 180°, with zone of belt strap, which changes direction, lying behind transparent wall of device. |
|
|
Application of acetylsalicylic acid salt for treatment of viral infections Group of inventions relates to medicine, namely to pharmacology and virology, and can be used for the prevention and treatment of viral infections, caused by RNA viruses with a negative chain, preferably flu viruses, first of all, viruses of H5 or H7 types. For this purpose a composition, containing a salt of o-acetylsalicylic acid with amino acid, selected from the group, including lysine, arginine, ornithine, diaminobutyric acid and a mixture of the said amino acids, is claimed. Also claimed is a method of applying an aerosol composition, which includes a salt of o-acetylsalicylic acid with natural or non-natural basic amino acid, a propellant and an optionally auxiliary substance and/or a carrier. The method involves aerogenic introduction of a physiologically active amount of the said aerosol composition to a person who is at risk of a viral infection or already infected by it, by inhalation through the nose or mouth. |
|
|
Invention refers to medicine and presents an inhalation device for a drug dose delivery; wherein the above inhalation device comprises an aid embedding a cell containing a drug; and an aid facilitating the drug removal arranged in the embedded cell and thereby enabling removing the drug from the above cell; the aid facilitating the drug removal comprises the first fluid path extending therethrough to supply the removed drug into an outlet opening of the inhalation device; what is also enclosed is an aid used to provide the second fluid path to supply the fluid into the above cell after the above aid facilitating the drug removal pierces a sealing material of the cell. |
|
|
Method and device for bringing inhalation device transformer into action Invention relates to medical equipment, in particular to inhalators in which a medication in a reservoir with a flat lower part is transformed into an aerosol state by means of a piezoelectric vibration transformer. Essence: a signal, which has the shape of a wave, containing two sinusoidal signals at two frequencies corresponding to the main resonance frequency and additional resonance frequency is sent to the transformer to create fluctuations at two or more different frequencies, including the main resonance frequency of the transformer and at least one additional resonance frequency of the transformer. |
|
|
Rehabilitation of children with chronic microbial-inflammatory urinary diseases with the low immune status is ensured by the staged rehabilitation treatment of patients in the stage of complete and partial clinical and laboratory remission. The first stage involves a complex whereat the patient is exposed to ultraviolet short-wave beams according to the standard technique including tonsils, and endonasally according to the standard technique every second day within the 16-21-day therapeutic course. That is followed by a helper stimulation of a chest by means of Helper apparatus with using 19, 20 and 21 sternal point for 3-5 minutes for each within the 7-10-day daily therapeutic course. Therapeutic exercises and phytotherapy are prescribed next with using essences, namely sage, or mint, or aniseed, or eucalypt essences, every second day within the 7-10-day therapeutic course. Thereafter, 3-4 months later at the second stage of rehabilitation, inhalations with immunopotentiating agents, namely 0.5% lysozyme, or sodium nucleinate, or aralia infusion, or ginseng infusion, or eleuterococcus infusion, or aloe extract are prescribed in the form of 10-15 minute daily procedures. The adrenal glands are stimulated with a low-frequency alternating magnetic field generated by Polus-1 stimulator, daily for 10-20 minutes within the therapeutic course of 10-20 procedures. That is followed by the helper stimulation of a thymus by means of Helper apparatus with using 19, 20 and 21 sternal point for 3-5 minutes for each within the 7-10-day therapeutic course. The patient does therapeutic exercises. At the 3rd stage 3-4 months later, the patient is subject to an extremely high frequency electromagnetic exposure covering the middle one-third of the sternum for 5-25 minutes within the therapeutic course of 8-10 procedures, daily or every second day; or the thymus helper stimulation is applied; or a splenin or interferon phonophoresis on the submandibular lymph nodes is alternated with a complex immune preparation on wings of nose with the length of exposure 2-3 minutes within the therapeutic course of 8-10 procedures daily or every second day. The complex certainly includes a halotherapy consisting in 12-25 daily session of the length of 30 minutes, a chest massage and therapeutic exercises. The final 4th stage involves cold water treatment as provided by standard techniques, helper stimulation of the sternum and feet, therapeutic massage, therapeutic exercises, swimming, pine baths or contrast shower. The length and therapeutic course are selected individually for each child. |
|
|
Invention refers to an inhaler comprising an outlet and closed compartments containing a therapeutic agent. The compartment currently coupled with the outlet opens with using an opening mechanism. An indexing mechanism sequentially couples the compartments with the outlet. A lock pin is used to lock the opening mechanism in a cocked position. The lock pin cannot lock the opening mechanism, until the indexing mechanism has coupled the following compartment with the outlet. The invention also refers to a method for preparing the inhaler for an inhalation procedure and a method for delivering the therapeutic agent from the inhaler. |
|
Invention relates to an aroma inhalation pipe including a hollow cylindrical pipe body (10), a tobacco cartridge (12) placed as a cartridge for aroma generation in the pipe body (10), a tip (30) connected to the tobacco cartridge (12) and projecting out of the pipe body (10) and a connective device (40) connecting the pipe body (10) and the tip (30) to each other; the connective device (40) has a connection position, wherein the tip (30) is clamped to the pipe body (10) with preset pushing force to elastically connect these two elements, and a free position that is assumed after the tip (30) being in the connection position, is pushed into the pipe body (10), turned and disengaged from connection to the pipe body (10). |
|
Inhaler with sound indicating means Group of inventions relates to versions of inhaler, which contains outlet hole, through which distribution of medication doses can be performed. Inhaler also contains mechanism of distribution, which has charged state, in which it is ready for performing dose distribution, and activated state, in which it has already performed dose distribution. In one aspect inhaler also contains blocking device, which after realisation of last dose distribution, is activated to switch off distribution mechanism from sound generation, which was heard when distribution mechanism moved from charged state into activated state. In second aspect blocking device prevents distribution mechanism from being in its charged state when cover of outlet hole is in open position, and as a result indicator "not ready" is shown to user. |
|
Inhaler with discrete motion interacting to lid motion Group of inventions relates to medicine, and in particular to a medical dispenser comprising an outlet and closed compartments containing a drug that are used for sequential alignment with the above outlet and dispensing through the above outlet; the invention also relates to a method of digital motion of the medical dispenser. The drive motion leads to an accumulation of the mechanical energy, and then a release of the mechanical energy, and conversion it into the discrete motion of the compartments. |
|
Invention refers to medicine, particularly to respiratory protectors against various aerosols (dust, various viruses, bacteria, etc.). The invention aims at providing higher effectiveness of the separation of aerosols, including those of submicron size. A tampon filter comprises a filter material with elements for placing in the user's nasal cavity. For the purpose of improving the effectiveness of the separation of aerosols, the filter is provided a power supply connected to a corona electrode electrically insulated and gapped from a conductive surface on a filter material electrically connected to the power supply housing. The presented design of the cartridge filter provides corona discharge generation in the air flow supplied into the filter material, and as a consequence, air aerosol particle charging. The electrically charged aerosol particles passing through the pore channels of the filter material are deposited on the earthed surface of the pores of the filter material. |
|
Method for dust salt generation and dust salt generator Group of inventions refers to medicine, particularly to a method for dust salt generation to be used in a salt therapy, and to a dust salt generator. The dust salt generator is used for implementing the above method. Dust salt is generated when the salt particles that move in the air flow collide with each other and certain portions of the dust salt generator, and adjusting the air flow rate and thereby changing its ability to move the salt particles enables increasing the number of collisions of the salt particles, and thereby providing the more efficient dust salt generation using obstacles, such as meshes placed in a dust salt generator vessel. |
|
Group of inventions refers to medicine. A nasal drug delivery device and a method for drug delivery into the patient's nasal air passage, wherein the nasal drug delivery device comprises: a mouthpiece used by the patient to exhale to close a posterior veil of soft palate; a tip placed into a patient's nostril with the tip comprising a nozzle used to deliver the drug into the nasal air passage when in use; and a manual delivery unit used to deliver the drug through the tip nozzle. |
|
Invention refers to medicine. A fluid outflow nozzle having an outflow tip which can be placed on an outflow device and comprises a fluid guide and an outflow hole at the end of the guide; the outflow hole adjoins a removable sealing element that may be moved into an open position, and for the purpose of fluid outflow release, the release tip and release device are moved axially towards each other; for this purpose, the release tip comprises a skirt to form a sliding guide with a section on the release device; the skirt of the release tip is coupled with another auxiliary skirt to form a ring cavity that can be mounted so that it can be movable axially on the section of the release device and formed as a ring rod. |
|
Invention refers to medicine, namely to paediatric anaesthesiology and resuscitation, and may be used for the prevention of bronchopulmonary displasia in newborns with very low or extremely low birth body weigth. For this purpose, the treatment regimen actual for the newborns on Biphasic/DuoPAP non-invasive artificial pulmonary ventilation through nasal cannula or CPAP artificial pulmonary ventilation through nasal cannula, or on invasive artificial pulmonary ventilation, is added with bolus administration of Surfactant BL from the 3rd-5th day of life in sessions of 10-15 min in a dose of 75 mg an hour. Surfactant BL is administered not later than from the 3rd-5th day of newborn's life. The preparation is administered in the amount of 75-150 ml within the therapeutic course. Omron or TravelNeb nebuliser is used. |
|
|
Method of treating acute pneumonias in debilitated patients living in industrial cities Invention refers to medicine, namely to pulmonology and physiotherapy, and may be used for treating acute pneumonias in debilitated patients living in industrial cities. That is ensured by 10 daily ultrasonic inhalations of 1% placenta hydrolysate at temperature 35°C for 10 minutes on an empty stomach or 40-60 minutes after meals. The inhalations are followed by the exposure to an ultra-high frequency electric field generated by automatically resonating UHF-80-3 Undaterm apparatus of output power up to 80 Wt, high-frequency oscillation frequency 27.12±0.6 MHz. The UHF exposure covers a patient sitting of a wooden chair. Condenser plates, each of the diameter 180 mm spaced 3 cm are placed on front and back surfaces of a chest above the inflammation centre from each side. An UHF dose is low-heat, has a power of 40-60 Wt; the procedure length is 10 minute; the therapeutic course makes 10 daily procedures. After 30 minutes, the UHF exposure is followed by medicine electrophoresis through 5% placenta hydrolysate applied on one of the temporary spacers. The exposure is generated by Potok-1 apparatus having current intensity 15-20 mA; the procedure length makes 20 minutes; the therapeutic course is 10 daily procedures with the patient lying on back on a bed. Two electrodes of the same size 10x15 cm are placed in a projection of the pathological centre, i.e. the first electrode is placed on the right or on the left on the back, and the second one - on the right or on the left at the front. |
|
|
Invention refers to medicine. A powder inhaler comprises a body with an inlet hole; an in-built storage element containing a drug powder; an in-built drug supply element comprising at least one concave area enclosing the drug capable to take up an enclosing position in relation to the storage element, wherein the concave portion encloses a pre-set amount of the drug, and an inhalation position, wherein the drug can be inhaled through the inlet hole; a mixing element for mixing the drug from the storage element; a start-up button movable between a starting position and a working position; whereas the start-up button reciprocates between the starting position and the working position, the concave area of the drug supply element moves from the enclosing position into the inhalation position, and the mixing element is actuated. |
|
Method for general health improvement in recurrent respiratory infection children Invention refers to medicine, namely paediatrics and may be used for the purpose of general health improvement in children suffering recurrent respiratory infections. The method involves the high-disperse dry sodium chloride aerosol inhalations with the halo-inhaler "Haloneb". A first generation mode providing haloaerosol at 0.5 mg/min is used in the children of 5-7 years old. The length of such treatment makes 5 minutes. A second generation mode (at 1 g/min) is used in the children of 8-14 years old for 10 minutes. Then, 10-15 minutes later the haloarosol therapy is followed by a breathing training on the basis of biological feedback using the computer hardware and software cardiopulmonological complex CHS-BOS-"BIOLOGICAL FEEDBACK". The length of the above training makes 10 min for the children of 5-7 years old, and 15 min - for the children of 8-14 years old. The therapeutic course is 10-12 daily procedures. |
|
|
Method for drug delivery in treating or preventing tobacco smoking and/or respiratory diseases Invention refers to medicine, namely to addiction medicine, psychotherapy, and pulmonology. What is used is an electronic cigarette containing a cartridge with a drug and trace amount of mint extract, and a blue light emitter. A monochromatic blue light emitter is actuated with air inhalation through the cigarette. The method enables reducing a dose of the drug administered by the blue light exposure with enhancing the therapeutic efficacy, reducing the requirement of nicotine by actuating the mechanism of nicotinic acid and nicotinamide self-reproduction from the nutrients, having the immune stimulating effect ensured by using blue light, increasing the patient's compliance by simplicity and familiarity of the device in use, eliminating the development of the stress response to smoking drop. |
|
|
Liquid-drop metered-dose inhaler Invention refers to medical equipment, namely to a liquid-drop metered-dose inhaler for drug delivery comprising an elongated tubular body; a drug container; a container holder detachably connected with the body; and also at least one axially-moveable piston; a dose setting handle used to set a dose ejected by accumulating a rotary force; a power-assisted mechanism transforming the rotary force into the axial force applied to the piston, and thereby generating a pressure inside the above drug container; an actuator mechanically connected with the power-assisted mechanism; a mouth-piece mechanically connected with the container holder; a drop generator having a number of through holes and mounted inside the mouth-piece with the holes being in the fluid connection with both the container, and the mouth-piece; the device further comprises a rotation dampener mechanically connected with the power-assisted mechanism to damp the initial pressure-jump inside the above drug container. |
|
Inhaler comprising carrier having large number of hermetic cavities containing drug preparation Group of inventions refers to versions of an inhaler, and a method of operation thereof. The inhaler comprises a carrier having series sealed cavities containing a drug preparation. To seal the drug preparation inside the respective cavities coupled to the carrier, a foil is attached to the carrier. Spacer elements each of which is coupled to the respective cavity and designed to separate the foil from the cavity are attached to the other side of the foil. Each spacer element can be moved from the coupled cavity by separating the sealing foil from the cavity which thereby opens to make the drug preparation be captured by the fluid flow; the spacer element with the attached foil is then placed back to seal the coupled cavity. |
|
Powder dispenser and method of powder capture in air flow 537 Group of inventions refers to a method of drug powder capture in the air flow; the above drug powder is found in a perforated cavity. The large air flow vortexes are provided by e.g. an obstacle created in a flow passage. The large-vortex air flow can pass the cavity perforation thereby creating the vortexes in the cavity that promotes the powder capture in the above air flow. |
|
Group of inventions refers to medicine. There are described dry powder inhalation systems for pulmonary drug delivery. The dry powder inhalation systems comprise a dry inhalation device or an inhalator and a cartridge comprising a pharmaceutical formulation containing an active ingredient for pulmonary circuit delivery. The presented devices represent reliable reusable devices which are provided with metered single-dose cartridges which deliver the drug linearly, and may be taken for pieces for the cleansing purposes. |
|
Drug dosage device with indication data display for user Invention refers to medicine. A dosage device comprises a drug release opening, an indication data display for a user, an opening lid movable between a first position wherein it closes the release opening and a second position wherein which the release opening is open. When the release opening is found in the first position, the indication data are exposed to view on the display. When the above lid is found in the second position, the indication data are invisible. |
|
Invention relates to medical equipment. An inhaler comprises an inhaler body having a space for accommodating a dry powder container, a vibration element, a flow channel, an electronic circuit for electrical actuation of the vibration element. The container comprises a lower wall, an upper wall and a side wall coupling the upper and lower walls. Besides, the inhaler comprises a drug release outlet on the upper wall of the container. The vibration has a flat surface coupled with a flat floor of the container to ensure the container vibration and to release the drug to be thereafter inhaled by the patient from the container through the drug release outlet into the flow channel. The container has an air inlet opening in its side wall. An area of the release outlet in the upper wall of the container is at least twice greater than that of one air inlet opening or than a total area of the air inlet openings in the side wall of the container. |
|
Inhaler comprising base having at least one drug-containing hermetic cavity Group of inventions refers to medical equipment. An inhaler comprises a base having at least one hermetically sealed cavity containing a drug and a foil having two sides with one side being attached to the base for hermetic sealing of the drug inside the cavity. A separating element is attached to the other side of the foil and used to separate the foil and cavity, wherein the separating element has a first end and an opposite second end wherein the separating element is movable to an inclined intermediate position wherein the above first end is spaced from the cavity. The separating element is also movable from the inclined intermediate position into the spaced position wherein the second end is also spaced from the cavity so as to remove the foil from the cavity which is thereby opens to ensure the possibility of capture of the drug contained therein in a fluid flow. |
|
Advanced dry powder delivery system System refers to endocrinology, and can be used for dry powder delivery to the airways. What is presented is an inhalation system comprising a dry powder inhaler and a dry powder. The system comprises a breath-actuated inhaler, or may be configured to release a powder jet. The inhalation system can change the air flow resistance value from approximately 0.065 to approximately 0.200 (kPa)/litre per minute. The powder contains a number of powdered diketopiperazine particles with a geometric mean diameter ranging within 2 mcm to 8 mcm and a geometric standard deviation less than 4 mcm. Powdered diketopiperazine administered per one inhalation and measured in plasma has AUC0-∞ more than 2300 ng×min/ml per mg in the dry powder. What is presented is the inhalation system configured to release more than 90% of the dry powder. After one inhalation, diketopiperazine particles are dissolved and absorbed in blood for less than 30 minutes with the peak concentration. The powder may contain a number of powdered insulin particles. Insulin administered per one inhalation and measured in exposed patient's plasma of AUC0-2h makes more than 160 mcUnits×min/ml per a unit of insulin. |
|
Invention relates to medical equipment. What is disclosed is a spray system with a drug container. According to one of the versions, the present invention involves a drug container a wall thickness of which makes approximately 100 to 240 mcm, and which can contain a pin hole to release and disperse the drug. |
|
Device and method for powder disaggregation Group of inventions refers to a device for inhalation of at least one air flow carrying a dose of a medical powder, and a method for powder disaggregation. The device comprises a flow passage extending by a cavity containing the powder. A portion of the passage extends along a flat surface. The flat surface has a hole of the cavity into said cavity containing the powder. When passing along the above flat surface and out of the above cavity, the air flow generates a swirl in the cavity, while the swirl generated promotes the powder disaggregation in the above cavity and the powder discharge from the above chamber. |
|
Invention refers to medicine. What is presented is an inhalation apparatus for aerosol formation for inhalation from a powdered drug preparation. The inhaler comprises an aerosol device having a chamber of substantially circular cross-section, an inlet and outlet holes on the opposite ends of the chamber for the drug preparation saturated air flow through the chamber between the mentioned holes, and an inlet hole for the extra fresh air flow inside the chamber. The extra air inlet hole is designed so that the air in the chamber through the mentioned inlet hole forms a cyclone in the chamber that interacts with the drug preparation saturated air flowing between the inlet and outlet holes. |
|
Invention refers to medicine. What is presented is an inhaler comprising a body for receiving a strip having a number of blisters with each blister having a destructible cover and containing a dose of a therapeutic preparation for inhalation by the user; an indexing wheel built in the body and rotating to drive the strip for the successive displacement of the blisters to align with the blister piercing element; a control element pivotally mounted on the body, and a drive mechanism designed to couple the control element and the indexing wheel during a part of rotation of the control element by the user so that to enable the indexing wheel rotating together with the control element. |
|
Invention refers to medicine. An inhaler comprises a body for receiving a strip having a surface and a number of blister cells descending from the mentioned surface. Each blister cell holds a dose of a drug preparation for inhalation by the user. The inhaler comprises a blister strip drive mechanism accommodating a blister strip drive member in the form to come into contact with the strip along a line drawn by a fold between the blister cell and the mentioned surface to drive the mentioned strip. |
|
Invention refers to medicine. What is presented is an inhaler comprising a body to accommodate the strip comprising a number of blisters with each blister having a pierced cover and containing a dose of the drug for inhalation by the user, a mouthpiece through which the dose of the drug is inhaled by the user, the cap for closing the mouthpiece and a blister piercing element to pierce the blister cover. The cap is rotatable to actuate the strip for the successive displacement of each blister to align with the blister piercing element. In response to the rotation of the cap, a drive element performs a function of actuating the blister piercing element to piece the cover of a combined blister so that when a user inhales through the mouthpiece, airflow is generated through the blister to entrain a dose contained in the blister, and the dose escapes from the blister and travels through the mouthpiece into the user's airway. |
|
Invention relates to medical equipment. An active inhaler for drug delivery comprises an inhalant carrier and a mouthpiece with one or more air supply holes. The inhaler possesses the flow resistance equal to min. 60000 Pa1/2s/m3. |
|
Group of inventions refers to medicine. A dose inhaler comprises a case body, an aerosol balloon comprising a balloon body, a valve rod and a syringe pressing the valve rod. The valve rod is held in the fixed position inside the case body. The balloon body is installed inside the case and movable if pressed against spring tension. A dose metre comprises at least one indicator element rotatable inside the case body. A control lever is rotatable inside the case body to rotate the indicator element. A control cap comprises at least one rotatable connective element coupled with the control lever. A cap section covers the balloon body from the bottom of the balloon case. The control cap vertically reciprocates by means of elastic spring tension which enables the control lever rotating from a first position into a second position and vice versa, and also enables the indicator element rotating. What is also disclosed is a version of a dosing cap differing by structural embodiment. |
|
Group of inventions refers to medicine. A dry inhalation system comprises a vibration mechanism functionally coupled with a dry powder feeder, a power source and a sensor. A feedback controller is coupled with the sensor and the power source. The feedback controller manages power supplied onto the vibration mechanism on the basis of vibration mechanism performance data presented by the sensor. What is also declared is a method for providing feedback control in the dry powder inhaler, describing, particularly inhaler operation. |
|
Method for improving clinical course of postoperative period in patients with ventral hernias Invention refers to medicine, namely to surgery and pulmonology, and may be used to improve the clinical course of the postoperative period in the patients with ventral hernias. A cough limit is determined one week before the operation. That is ensured by nebuliser inhalations of citric acid solutions in increasing concentrations into patient's airways by 5-second slow inhalation after maximum exhalations for three times every 10 seconds. The inhalation is continued till observing five and more coughs running or if achieving the highest concentration of the solution. The sensitivity threshold of the cough receptors is considered to be the maximum concentration of the citric acid solution causing 5 and more coughs, in case the solution inhalation with the further concentration also causes coughing. If the cough limit makes 2.5 g/l and lower, high sensitivity of the cough receptors is stated. That required the postoperative administration of the preparation indicated for the antitussive therapy, e.g. Stoptussin 1 tablet 3 times a day, at least 5 days before the operation and for 7 days after. If the cough limit makes 2.6 to 10 g/l, moderate sensitivity of the cough receptors is concluded. In this case, Soptussin is administered in a dose of 1 tablet 2 times a day 3 days before the surgical management and for 5 days thereafter. If the cough limit makes 10 g/l and more, lower sensitivity of the cough receptors in the person being tested is stated, and no antitussive preparations prescribed. |
|
|
Group of inventions refers to medicine. There are disclosed an inhaler and a method of controlling a blister strip. An inhaler comprises a body for enclosing an extended blister strip each of which contains a drug dose which sequentially moves into a position matched with a blister piercer that enables inhaling said dose contained in the given blister. The device comprises a spiral element integrated in the body wherein said strip with opened blisters arrives and winds. |
|
Interactive system and method for real-time force profiling in inhalation Group of inventions refers to medicine. There are described systems for inhalation, inhaler control, an interactive system and methods for detection and measurement of performance diagrams when an individual uses the real-time system for dry powder inhalation. The system for inhalation contains a dry powder inhaler with a cartridge and a sensor. A control system comprises a control unit, a data medium and an analogue-digital converter. The interactive system comprises a dry powder inhaler, a measuring transducer and a display unit. The systems may be used for wireless or wire connection with the display unit for the purpose of assessing whether the individual applies the system for inhalation correctly, assessing performance characteristics of the system for inhalation and/or evaluating the medical dry powder flow from the system for inhalation when in use. |
|
Invention relates to medical equipment. In an inhaler for powder drug introduction, a blister cavity opened by a piercing element is provided in a lower portion of a body which consists of an upper portion presented in the form of a mouthpiece and an inhalation passage, and a lower portion which contains an air inlet. The inhalation passage of the upper portion contains a powder drug dispersion unit with said unit coupled with piercing elements, with the upper portion of the body movable with respect to the lower portion of the body for opening the blister cavity. |
|
Dosing device for powdery substance inhalation Invention is intended for bringing dosing rod from storage chamber into ready for emptying position by means of dosing chamber. In particular, in order to facilitate dosing chamber, invention offers rod-elongating tongues for closing dosing chamber. |
|
Dry powder inhaler and drug delivery system Group of inventions refers to medicine. There are presented breathing-actuated dry powder inhaler, a cartridge and respiratory drug delivery systems. The inhaler and/or the cartridge may be provided with a drug preparation to be delivered, including e.g. diketopiperazine, and an active ingredient, including peptides and proteins, such as insulin and glucagon-like peptide 1 for treating diabetes and/or obesity. The dry powder inhaler is compact and comprises a case, a mouth-piece, a cartridge seat and an opening/closing mechanism for the drug cartridge. |
|
Dosing device for inhalation of powder substance Invention refers to medical equipment and concerns a dosing device actuated by air flow sucked up by a user and intended for inhalation of a powder substance, particularly for medical applications, kept in a storage container brought into a releasable ready position when decapping a mouthpiece by a dosing chamber of a dosing rod. Particularly, for the purpose of improved release, the invention offers providing two air flow passages one of which is used to release from the dosing chamber, and/or another air flow passage runs to a ring chamber directly to mix air with a substance-containing air flow. |
|
Method of treating bronchopulmonary diseases Invention relates to medicine, namely to pulmonology, and can be used for treatment of bronchopulmonary diseases. For this purpose traditional drug treatment of pathology is carried out, additionally performed is impact by infrared laser radiation (IRLR) and successive inhalation of mineral water aerosols. Impact by infrared laser radiation is performed on projection of bronchi and lungs with total superficial energy density 0.06-0.65 J/cm2 for 4-8 minutes per 1 procedure. For inhalation used are aerosols of mineral water in dose 6-15 ml with temperature 40-42°C. Inhalation is performed for 4-10 minutes per 1 procedure. Course of therapy constitutes 7-12 daily performed procedures. |
|
|
Method of treating patients with bronchial asthma with accompanying hypertension Invention relates to medicine, namely to therapy, physiotherapy, balneology. Method includes carrying out respiratory gymnastics, inhalations with mineral water, manual massage of chest, applications of peloids, electric stimulation at the background of drug basic therapy. During electric stimulation impact is performed by high-amplitude pulse current with biological feedback, with frequency 90-100 Hz and gradually increasing current intensity until sensation of painless vibration appears. On the first day impact is performed paravertebrally at the level D1-D7 and along 7-8 intercostal spaces. On the second day impact is performed paravertebrally and on collar area. Peloid therapy is carried out 20-30 minutes after electric stimulation. In first application impact is performed on chest at temperature 38-40°C and 20-30 minute exposure. On the second day of application impact is performed on collar area at temperature 35-36°C. Course of treatment includes 6-7 coupled impacts on each zone. |
|
Powder spraying apparatus, method for manufacturing and using it, its components Group of inventions refers to medicine. There are declared an apparatus and its components for the pulmonary introduction of a composition, e.g. for dispersion of dry powders of drugs for inhalations by the patient. There are described components and characteristics of the apparatus versions including container piercing mechanisms, cleaning devices, blow hammer for the container, and container block devices and mechanisms. |
|
Method for body spare capacities recovery Invention refers to restorative and sports medicine, physiotherapy and may be used for sportsmen's body spare capacities recovery. That is ensured by prescribing drinking mineral water commercially produced with trade name "Chvizhepse" 200 ml 3 times a day 40 minutes before meals and between meals, 2.5 ml a day for 14 days. Temperature of mineral water makes 15-18°C. From the third day of therapy, 5-minute intranasal inhalation by the Boreal F 400 apparatus with the preparation 1.8-2.0 ml containing biologically active substances 10 mg of animal origin in each 450 ml of physiologic saline. The preparation represents a perfusate prepared by passing through a hemofilter filled with mixed ground vital animal organs such as thyroid, spleen, the tail of the pancreas, epinephros, kidneys, hypothalamus, hypophysis, epiphysis, physiologic saline or blood-substitute liquid. The first inhalation is conducted 2 hours after breakfast, while the second one is prescribed two hours after the first one, and the third one - in 7 days two hours after breakfast. |
|
|
Method of improvement of organism of 7-10 years old children in conditions of comprehensive school Invention relates to medicine, namely to pediatrics, in particular to physical training of 7-10 years old children in school conditions. For this purpose during lesson of physical training exercises are performed in conditions of saturation of gymnasium with sea water aerosol. Selection of physical exercises is performed depending of season. In autumn season period exercises developing endurance, constitute 30-40% from total number of exercises. In winter period exercises developing speed-force abilities constitute not less than 30% of total number; exercises, developing flexibility constitute not less than 20%; exercises developing coordination abilities constitute not less than 30%. In spring period exercises developing speed abilities correspond 30-40% of total number of exercises. Saturation of gymnasium with sea water aerosol is performed in two stages. First stage is carried out at the end of autumn and beginning of winter period in course of final part of each lesson, 4 minutes long, increasing this time after each four lessons by 2 minutes until 8-10 minutes duration is achieved. Second stage is carried out at the end of winter period and beginning of spring period in the course of main part of lesson with 10 minutes duration, gradually increasing this time after each four lessons by 5 minutes until 5-35 minutes duration 2 is achieved. Saturation of gymnasium with sea water aerosol is realised during 15-17 days in each period. Multivitamin complex is additionally introduced at the end of the lesson after saturation of gymnasium with sea water aerosol. |
|
Method of treating patients with arterial hypertension with metabolic disorders Invention relates to medicine, namely to cardiology, physiotherapy. Method includes carrying out medical and physical training complex, "dry" carbon dioxide baths, hydrogen sulfide baths. Manual classical massage of neck-collar zone, hypoxytherapy "Mountain air" and four-chamber contrast baths on upper and lower extremities are additionally carried out. Course of treatment constitutes 20 days. Daily carried out are medical physical training including 15-20 exercises, manual massage of neck-collar zone 10-15, hypoxytherapy "Mountain air" 10-15 in number and four-chamber contrast baths on upper and lower extremities 10-15 in number. "Dry" carbon dioxide baths are carried out every second day, 10 procedures, for 15-20 minutes, at temperature 35-37°C. They are alternated with hydrogen sulfide baths at temperature 35-37°C, 10 procedures, for 15-20 minutes. Hypoxytherapy is carried out with gradual reduction of procedure time from 60 to 30 minutes and reduction of percent content of oxygen to 10-12%. Four-chamber contrast baths are carried out for 10 minutes in 9 modes, with change of temperature from 22°C to 42°C. |
Another patent 2513329.